319
Views
2
CrossRef citations to date
0
Altmetric
Letter

Comments on “Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: Comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6

, &
Page 334 | Published online: 01 May 2009

References

  • Eddleston M, Eyer P, Worek F, Mohamed F, Senarathna L, von ML et al. Differences between organophosphorus insecticides in human self-poisoning: a prospective cohort study. Lancet 2005; 22; 366:1452–9.
  • Eyer F, Meischner V, Kiderlen D, Thiermann H, Worek F, Haberkorn M et al. Human parathion poisoning. A toxicokinetic analysis. Toxicol Rev 2003;22:143–63.
  • Lorke DE, Hasan MY, Nurulain SM, Kua K, Schmitt A, and Petroianu GA. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6”, Clinical Toxicology, 2008a. DOI: 10.1080/15376510802312365 URL:http://dx.doi.org/10.1080/15376510802312365 Accessed 16 January 2009
  • Lorke DE, Nurulain SM, Hasan MY, Kuca K, Musilek K, Petroianu GA. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity. J Appl Toxicol 2008b; 28:920–8.
  • Worek F, Eyer P, Szinicz L, Thiermann H. Simulation of cholinesterase status at different scenarios of nerve agent exposure. Toxicology 2007; 233:155–65.
  • Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004; 1;68:2237–48.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.